| Tag | Content |
|---|
EnhancerAtlas ID | HS037-20852 |
Organism | Homo sapiens |
Tissue/cell | ESC |
Coordinate | chr2:160643300-160645600 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr2:160644620-160644641 | AAAAAAAAAGAAAAAGAAAAA | - | 6.09 | | MYC | MA0147.3 | chr2:160644932-160644944 | CAGCACGTGGCC | - | 6.37 | | NFAT5 | MA0606.1 | chr2:160644250-160644260 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr2:160644250-160644260 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr2:160644250-160644260 | ATTTTCCATT | + | 6.02 | | RORA | MA0071.1 | chr2:160644031-160644041 | TGACCTTGAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09505 | chr2:160643202-160644340 | CD14 | | SE_09505 | chr2:160644433-160650883 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 160644176 | 160644404 | | chr2 | 160644852 | 160645009 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH02I159786 | chr2 | 160643203 | 160644340 | | GH02I159788 | chr2 | 160644881 | 160645030 |
|
Enhancer Sequence | TTCTTTTATT TTTTGGTGAA TTTTTTATAA AGTAAACATA CCCATATAAT TATCAGAGGA 60
ATGAGGAACA GAACATTAAC CCCTTTTGCT CACCATCCCT TCCAAAGGTC ATCTCTAACC 120
TAACTTCTAA CACCATCGAT TAGTTTTGCC TGTTTTTGAA CTTTATAGTT ATGGAATCAT 180
ACATTGTGTA CTCTTTTGTG TCTGGCTTCT TTTGATAAAT GTTACTTTAA AAATCATTTT 240
ATTTAAGACT TATCTAAGAA CTTATTCATT CTTCTGTTGA TGAATATTTG GGTAGTTTCT 300
AGTTTGTGGC CATTGTAATG CTGCTTTAAA CATTCTATGC ATACTTCTTG TGAGTACCTT 360
TGTAGAAGTA GATTGCTGGG GCCATCGAGT ATGCATGTGC CCAGCTTTCA CAGATACTGC 420
CAAACACTTT TTCTAAGTAG TTATAATTCT TGCAAGCAGC AAGTAGTTTT TTTTTAAATC 480
CAGCTTGATC ACCTTTGTCT TTTAATTGAA GTATTTCCAG TAATACTTAA TGTAGTTACG 540
ATGAATTGGA GTTTATATCT ACCATCTTAA TATTTGTTTT TCATTTGTCC TACTTATTTT 600
ATGTTCCTTT TTTCTCATTT ATTGTCTTTT TTGTATTAAA CATTTTATAT TTGATCCTTT 660
TTCTTTTAGC TTGTTAATTA TATATTCTTT AATTTTTTTT CTGTAGTAGC TACCCTGAAA 720
ATTATAATAT GTGACCTTGA TTTATTAATA CCTCAAATAA ATCAGTACTT TTACCACTTC 780
CTAGGCAGTC CTAGAAACAT ACAATATTTT AATTTCATTG GCTTCCTTTC CTTTATCTTA 840
TTGTTTTATT ACTGTTTTGC CTGGCCGGTG TTCTTTTAGA TTTAAATACA TATTTACCCT 900
CTCTGTTGCT CTTCATTCCT TCTCGCATTT CTGTATTACT GACTGGGATA ATTTTCCATT 960
TGCCTAAAGA AATCTCTTTG GTGTTTCTTT AAGTGCAGGT CTACTGGAAA CTCCCTCAGT 1020
TCTTGATACT CTATAAATGT CTCCACCAGG CACAGTGGCT CACGCCTGTA ATCCCAGCAC 1080
CGAGGTGGGT GGATCACCTG AGGTCAGGAA TTTGAGACCA GCCTGGCCAA CATGGTGAAA 1140
ACCTGTCTCT ACTAAAAAAT ACAAAAAATT AGCTGGGTGT GGTGGCGGGT GCCTGTAATC 1200
CCAGCTATTG GGGAGCCTGA GGCAGGAGAA TCACTTGAAC CCAGGAGGCG GAGGTTGCAG 1260
TGAGCCAAGA TTGCACCACT GCACTCCAGC CTGACAACAG AGTGAGACTC CGTCTCAAAA 1320
AAAAAAAAAG AAAAAGAAAA AAGGTCTTTA TACTGTCTTC ATGTTTGATG GCTATCTTTG 1380
CAAATACAGA ATTGTAGAAT GGCAGCTTAT CTTTCATTTA AGATGTACAT AGTCATGCAC 1440
CATATAATGA CATCTTGGTC AATGATAGAC TATATATGGC AGGGTTCCCA TGAGGTTATA 1500
ATACCATTAT TTTTACTGTG CTTTTGCTAT GTTTAGAAAC ACAAATACTT ATGTTGTGCT 1560
ACAATTGCCT ACAGTATTCA GTATAGCAAC ATGCCATACA GGTTCCGCAA GTTACTGCAG 1620
AGCAATAGGC TCCAGCACGT GGCCTAGGTG TGTAGTAGGC ATACCATCTA GGTTTGTGTA 1680
AGTACACTCT ACGATGTTTG CACAATGACA AAATTGCCTA ATGAAAAATT GCATTTCTCA 1740
AAATGTATCC CTGTTGTTAA TTAAGCAATG AATCACTATA GTTTTGTTGC TTGGGCTTCC 1800
ATCATTTCTA CTGAGAAGTT AACTGTCAGT CTCACTGTTG CTTTTTGGAC AGTAATGTGC 1860
TTTTCCCCCT TCTTGCTGCT TTCAAGATTT TCTTTGTCTT CGGTTTTTAG CAGTTTTACA 1920
GTGGCATGCT GTTGTTTTAG TGTTTTTAAA TCCTGCTAAG AATTCAATGC ACTTTCTGAA 1980
TCTGTGGCTT ATTTTCATTG GTCACTTTTG AAAAGTTCTT GGCCATTATC ATTTCAGATG 2040
CTACTTTTGC TCCATTCTCT CTCTCTTCCC TTTCTGGGAC CAAAATTACA TCTATGTTAG 2100
ACTTTTTACC ATGTCCTGTA TATCCTTTTG CTCTTTTCAA TACTGTTAAT ACTCTCCATA 2160
ATATAATCTC ATTCTTCCTG GTTTATTAAT GCACTCTTAA GTTGTAACTT AACTGGGGTA 2220
AGGGTAACTC CAATTTTTTT TTTTTTAAGA CAAGATCTCT CTCTGTCACC CAGGCTGGGG 2280
TACAATGGCA TGGTCATAGC 2300
|
